What is LBRX's EBITDA?

LBRX (LBRX) reported EBITDA of -$18.97M in Q1 2026.

How has LBRX's EBITDA changed year-over-year?

LBRX's EBITDA decreased by 263.0% year-over-year, from -$5.23M to -$18.97M.

What does EBITDA mean?

Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.

LBRX LBRX EBITDA

EBITDA at other companies

MapLight Therapeutics, Inc. MPLT

-$64.34M-175%

Alto NeuroscienceANRO

-$26.95M-73.8%

Zevra Therapeutics, Inc.ZVRA

$52.51M+1,514%

Opko HealthOPK

-$28.82M+34.0%

Bristol-Myers SquibbBMY

——

AlkermesALKS

——

Other financials

Income statement

See full

Net income-$19.1M-259%

EPS (diluted)-$0.67+95.5%

Balance sheet

See full

Cash & equivalents$320.7M—

Total debt$3.5M—

Total equity$378.7M+481%

Total assets$393.5M—

Cash flow

See full

Operating cash flow-$23.3M-187%

CapEx$32.0K+52.4%

Free cash flow-$23.3M-186%

Valuation

See full

Market cap$874.06M+163%

Enterprise value$556.86M—

Returns & leverage

See full

Return on equity-27.9%—

Debt / equity0×—

Current ratio35.7×—

Where this comes from

Calculated from LBRX’s reported figures.

−$19.1Mebit+

$82.0KDepreciation Depletion & Amortization

=-$18.97M

The official record: LBRX’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about LBRX's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is LBRX's EBITDA?: LBRX (LBRX) reported EBITDA of -$18.97M in Q1 2026.
How has LBRX's EBITDA changed year-over-year?: LBRX's EBITDA decreased by 263.0% year-over-year, from -$5.23M to -$18.97M.
What does EBITDA mean?: Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.